Brief: Calliditas Therapeutics Proposes No Dividend For 2023
21/02/2024 06:08
Feb 21 (Reuters) - Calliditas Therapeutics AB
CALTX.ST :
* FOR YEAR ENDED DECEMBER 31, 2023, NO DIVIDEND IS PROPOSED
* OUTLOOK 2024: TOTAL NET SALES ARE ESTIMATED TO BE USD
150-180
MILLION FOR YEAR ENDING DECEMBER 31, 2024
Source text for Eikon: ID:nWkrc0YXHS
Further company coverage: CALTX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Calliditas Therapeutics AB
See all newsBrief: Calliditas To Be Delisted From Nasdaq Stockholm
Brief: Calliditas Therapeutics Takes Certain Corporate Actions Following Announcement By Asahi Kasei
Brief: Asahi Kasei Corp: Notice Regarding Results Of Tender Offer For Shares Of Calliditas Therapeutics AB And Transfer Of Subsidiary
Calliditas Therapeutics AB reports results for the quarter ended in January - Earnings Summary
Brief: Calliditas Q2 Sales Beat Expectations